An article entitled "Clinical features and management of haemophilic pseudotumours: a single US centre experience over a 30-year period" was published in the January 2014 issue of the journal Haemophilia. The authors are UNC clinicians Ming Y. Lim, MBBChir; Brenda Nielsen, MSN; Alice Ma, MD; and Nigel Key, MD.
On December 23, the U.S. Food and Drug Administration approved Tretten (coagulation factor XIII A-subunit [recombinant]) for use in the routine prevention of bleeding in adults and children who have congenital Factor XIII A-subunit deficiency, a rare clotting disorder.
Researchers package specialized blood platelets with genes that express clotting factor, leading to fewer bleeding events.
Registration is now open for the 7th UNC Symposium on Hemostasis, May 15-17, 2014, in Chapel Hill. The symposium is entitled "Old System, New Players, New Directions."
The UNC TarHealers walking team raised $1,675 for Hemophilia of North Carolina, the state chapter of the National Hemophilia Foundation.
The Clot Connect program was featured prominently in an "Impact Your World" segment on CNN and Headline News.
Gene therapy research at UNC-Chapel Hill is spotlighted in National Hemophilia Foundation publication
This month's "HemAware" magazine from the National Hemophilia Foundation features a story on gene therapy research.
On September 27, 2013, Hemophilia of North Carolina Board President Steve Peretti announced that Charlene Cowell has been named as HNC's new Executive Director effective September 19.
Faculty and staff members from UNC-Chapel Hill have formed the UNC TarHealers team to raise funds at the 2014 Hemophilia Walk in Morrisville, NC on Saturday, October 11, 2014.
UNC's Drs. Nigel Key and Alice Ma discuss hemophilia and Drs. Ma and Paul Monahan explain von Willebrand disease on this educational television show.
Dr. Buckner received a two-year award (July 1, 2013 - June 30, 2015) to support clinical and research training in bleeding and clotting disorders.
Paul E. Monahan, MD, received the Leadership in Research Award from the National Hemophilia Foundation at NHF's 65th anniversary reception in New York City on June 12.
Dr. Lim has been chosen as a recipient of the ASH Training Award for Fellows for the period July 1, 2013 - June 30, 2014. The title of her project is "'Contribution of erythrocytes to thrombin generation in sickle cell disease."
Members of the UNC Hemostasis/Thrombosis Group gave 21 oral presentations and presented five posters at the biannual meeting of the International Society on Thrombosis and Hemostasis in Amsterdam July 1-4, 2013.
Dr. Buckner was awarded the first Hemostasis and Thrombosis Research Society/Novo Nordisk Clinical Research Fellowship in Hemophilia and Rare Bleeding Disorders at the HTRS meeting held April 11-13, 2013 in Charlotte, NC.
In December 2012, the UNC Hemophilia Clinic began seeing adult patients with hemophilia and other bleeding disorders at Carolina Pointe II for routine clinic appointments.
The UNC TarHealers walker team raised $1,845 for Hemophilia of North Carolina, the state chapter of the National Hemophilia Foundation.
Information concerning the storage and use of temperature-sensitive biological products that have been involved in a temporary electrical power failure or flood conditions.
Raj Kasthuri, MD, is director of the new center of excellence for the treatment of hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, an inherited disorder of the blood vessels that can cause excessive bleeding.